Erythropoietin, iron, and erythropoiesis
Open Access
- 1 August 2000
- journal article
- Published by American Society of Hematology in Blood
- Vol. 96 (3) , 823-833
Abstract
Recent knowledge gained regarding the relationship between erythropoietin, iron, and erythropoiesis in patients with blood loss anemia, with or without recombinant human erythropoietin therapy, has implications for patient management. Under conditions of significant blood loss, erythropoietin therapy, or both, iron-restricted erythropoiesis is evident, even in the presence of storage iron and iron oral supplementation. Intravenous iron therapy in renal dialysis patients undergoing erythropoietin therapy can produce hematologic responses with serum ferritin levels up to 400 μg/L, indicating that traditional biochemical markers of storage iron in patients with anemia caused by chronic disease are unhelpful in the assessment of iron status. Newer measurements of erythrocyte and reticulocyte indices using automated counters show promise in the evaluation of iron-restricted erythropoiesis. Assays for serum erythropoietin and the transferrin receptor are valuable tools for clinical research, but their roles in routine clinical practice remain undefined. The availability of safer intravenous iron preparations allows for carefully controlled studies of their value in patients undergoing erythropoietin therapy or experiencing blood loss, or both.Keywords
This publication has 146 references indexed in Scilit:
- Controversy. Measurement of hypochromic red blood cells is not the first line procedure to identify the patient with iron deficiencyNephrology Dialysis Transplantation, 1998
- Kinetics of reticulocyte maturity fractions and indices and iron status during therapy with epoetin beta (recombinant human erythropoietin) in cardiac surgery patientsAmerican Journal of Hematology, 1997
- Intravenous administration of iron gluconate during haemodialysisNephrology Dialysis Transplantation, 1997
- Inadequate erythropoietin response to anemia: definition and clinical relevanceAnnals of Hematology, 1994
- The effect of oral iron supplementation on erythropoiesis in autologous blood donorsTransfusion, 1992
- Erythropoietin Treatment of Anemia Associated with Multiple MyelomaNew England Journal of Medicine, 1990
- Decreased Erythropoietin Response in Patients with the Anemia of CancerNew England Journal of Medicine, 1990
- Increased Preoperative Collection of Autologous Blood with Recombinant Human Erythropoietin TherapyNew England Journal of Medicine, 1989
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- Perspectives in Iron MetabolismNew England Journal of Medicine, 1982